Volunteers sought for vaccine trials

Volunteers sought for vaccine trials

Volunteers sought for vaccine trials

The National Institute for Health Research (NIHR), research partner of the NHS, is seeking volunteers for Covid-19 vaccine trials in England.

There are currently 2 national coronavirus vaccine studies approved by NIHR in the UK.

These are being run by the University of Oxford and Imperial College London.

According to the NHS, the vaccines are designed so that they do not give people the infection they’re protecting against.

Researchers are seeking people from all backgrounds in order to determine the effectiveness of potential vaccines.

The organisation have said that they are especially interested in hearing from those who “are more likely to benefit from a vaccine” including over 65s, frontline health and social care workers, and those from Black, Asian and Minority Ethnic backgrounds.

Over 100,000 people have already applied to take part in the trial.

Chief Executive of the NIHR’s Clinical Research Network Dr William van’t Hoff said:

“I’m really grateful to the volunteers who have signed up to the NHS vaccine registry so that we have reached the important milestone of 100,000 people registered in less than a month.

“I also want to praise the staff from the research community, NIHR and NHS, who have worked so well in partnership to achieve rapid recruitment into trials to tackle COVID-19.

“I would encourage everyone who hasn’t already signed up to look at the website and consider whether they would like to join the register, before the large-scale vaccine trials start in the coming weeks.”

Consultant Respiratory Physician and Director of the National Institute for Health Research (NIHR) PRC, Bradford, Dinesh Saralaya added:

“The best way to protect us from future outbreaks is to develop effective vaccines.

“Several vaccine trials are being conducted around the UK in the coming months and it is important that we all sign up to be contacted about them.

“By working together, we can produce efficient vaccines which are likely to protect all sections of our society from this dreadful virus in future.”

Contact Gi National
Email us: